The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect

F GoetzA Graessmann


We report here for the first time, that the SV40 small t-antigen inhibits mammary gland differentiation during mid-pregnancy and that about 10% of multiparous WAP-SVt transgenic animals develop breast tumors with latencies ranging from 10-17 months. Cyclin D1 is deregulated and over expressed in the small t-antigen positive mammary gland epithelial cells (ME-cells) and in the breast tumor cells. SV40 small t-antigen immortalized ME-cells (t-ME-cells) exhibit a strong intranuclear cyclin D1 staining, also in the absence of external growth factors and the cells continue to divide for several days without serum. In addition, the expression rate of cyclin E and p21(Waf1) but not of p53 is increased. Coimmunoprecipitation experiments revealed that p21(Waf1) is mainly associated with the cyclin D/CDK4 but not with the cyclin E/CDK2 complex. WAP-SVT transgenic animals exhibit an almost regular mammary gland development until late pregnancy but the majority of the ME-cells are eliminated by apoptosis during the early lactation period. Tumor formation is delayed and less efficient than in T/t-antigen positive animals. Sequestration of p53 and pRb by the N-terminal truncated T-antigen molecules (T1-antigen and T2-antigen) does not affect...Continue Reading


Jan 4, 1979·Biochimica Et Biophysica Acta·S Sakai, M R Banerjee
Nov 1, 1990·Endocrinology·S WangS Z Haslam
Jun 1, 1997·American Journal of Clinical Pathology·E WakasugiM Monden
May 1, 1997·Journal of Clinical Pathology·E WakasugiM Monden
Aug 12, 1999·Biologicals : Journal of the International Association of Biological Standardization·J A DeCaprio
Mar 14, 2000·Current Opinion in Cell Biology·D M Virshup
Jun 8, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·P M SiegelW J Muller
Sep 1, 2000·Biochimica Et Biophysica Acta·G P Dotto
Oct 12, 2000·Free Radical Biology & Medicine·S KohlhoffM Graessmann


Jan 22, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Andreas KleinA Graessmann
Jul 4, 2006·Nature Reviews. Drug Discovery·Grzegorz NalepaJ Wade Harper
Jul 14, 2010·Cancer Genetics and Cytogenetics·Andreas KleinPeter Duesberg
Jun 10, 2009·Seminars in Cancer Biology·Jingwei ChengBrian S Schaffhausen
Aug 22, 2012·International Journal of Cancer. Journal International Du Cancer·Benjamin OttoGenrich V Tolstonog
May 13, 2005·Mutation Research·Qiang Shen, Powel H Brown
Jun 8, 2002·Breast Cancer Research : BCR·Anneke C Blackburn, D Joseph Jerry
Oct 31, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Malekpour Afshar RezaZeinali Nejad Hamid
Apr 14, 2018·Frontiers in Cell and Developmental Biology·Hidetoshi MoriAlexander D Borowsky
Oct 1, 2009·Cancer Prevention Research·Brian C TrainorR D Cardiff

Related Concepts

Simian Sarcoma Virus Proteins
Cell Differentiation Process
Neoplastic Cell Transformation
Mammary Neoplasms, Experimental
Founder Mice, Transgenic
Protein p53
Retinoblastoma Protein
Cyclin D1

Related Feeds


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis